Effects of Compound Ursodeoxycholic Acid Oral Liquid on Hepatic Fibrosis in Rats

Mei-gui YOU,Mei SU,Tong CHEN,Hui JI
DOI: https://doi.org/10.13664/j.cnki.pcr.2016.04.006
2016-01-01
Abstract:Objective: The study was designed to observe the effects of C-UDCA on hepatic fibrosis in rats. Methods: The effects of C-UDCA on experimental hepatic fibrosis were observed in model rats in-duced by carbon tetrachloride. Intragastric administration of different doses of C-UDCA was followed by determination of serum ALT, AST, HA, LN, PCⅢ and CⅣ and live GSH and Hyp. Histopathological changes in liver tissues were also examined by HE staining. Results: In comparison with the model group, all doses of C-UDCA significantly reduced the levels of serum ALT, AST, HA, PCⅢ, CⅣand LN, and the content of Hyp in liver tissues. Moreover, the contents of GSH in liver tissues were elevated. Compared with UDCA, C-UDCA-H remarkably decreased the levels of serum ALT, AST, HA, PCⅢ, CⅣ and LN and the contents of Hyp in liver tissues, while the contents of GSH in liver tissues were significantly ele-vated. Meanwhile, C-UDCA-M also obviously lowered the levels of serum HA and LN. Conclusion: Our data suggested that C-UDCA could significantly improve liver function from fibrogenesis and deday the liv-er pathological changes. Furthermore, C-UDCA-H and C-UDCA-M were more effective than UDCA.
What problem does this paper attempt to address?